Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Korro Bio (KRRO) Depreciation & Amortization (CF) (2019 - 2025)

Korro Bio's Depreciation & Amortization (CF) history spans 7 years, with the latest figure at $649000.0 for Q4 2025.

  • For the quarter ending Q4 2025, Depreciation & Amortization (CF) fell 50.08% year-over-year to $649000.0, compared with a TTM value of $4.3 million through Dec 2025, up 17.87%, and an annual FY2025 reading of $4.3 million, up 18.89% over the prior year.
  • Depreciation & Amortization (CF) for Q4 2025 was $649000.0 at Korro Bio, down from $1.2 million in the prior quarter.
  • The five-year high for Depreciation & Amortization (CF) was $1.3 million in Q4 2024, with the low at $382000.0 in Q1 2021.
  • Average Depreciation & Amortization (CF) over 5 years is $793150.0, with a median of $730500.0 recorded in 2021.
  • Year-over-year, Depreciation & Amortization (CF) soared 277.46% in 2021 and then tumbled 50.08% in 2025.
  • Tracing KRRO's Depreciation & Amortization (CF) over 5 years: stood at $737000.0 in 2021, then plummeted by 44.91% to $406000.0 in 2022, then skyrocketed by 146.31% to $1.0 million in 2023, then grew by 30.0% to $1.3 million in 2024, then tumbled by 50.08% to $649000.0 in 2025.
  • Per Business Quant, the three most recent readings for KRRO's Depreciation & Amortization (CF) are $649000.0 (Q4 2025), $1.2 million (Q3 2025), and $1.2 million (Q2 2025).